Mouse Hypothalamic Somatostatin Release: Roles of Calcium and Calmodulin*
- 1 July 1985
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 117 (1) , 369-375
- https://doi.org/10.1210/endo-117-1-369
Abstract
A short term system of dispersed adult mouse hypothalamic cells, as previously described in the rat, was employed to examine the roles of Ca and calmodulin in SRIF [somatostatin] release. Incubation studies were performed 24 h after hypothalamic cell dispersion. SRIF release, as determined by RIA [radioimmunoassay] was stimulated in a dose-dependent manner by the membrane-depolarizing agents KCl, ouabain and veratridine as well as by the Ca ionophore A23187 [calcimycin]. The stimulation of SRIF release induced by depolarizing agents was abolished or diminished by omission of extracellular Ca, chelation of extracellular Ca by EGTA, the Ca channel blocker verapamil, indicating Ca dependence of this process. Three chemically distinct groups of calmodulin inhibitors were employed to study the role of calmodulin in stimulus-secretion coupling of hypothalamic SRIF. The neuroleptic calmodulin inhibitors trifluperazine (1 .mu.M), chlorpromazine (10 .mu.M) and promethazine (10 .mu.M) as well as the naphthalene sulfonamide calmodulin inhibitor Wt [N-(6-aminohexyl-5-chloro-1-naphthalene-sulfonamide)] (1 .mu.M) and compound 48/80 (50 .mu.g/ml) were all demonstrated to have an inhibitory effect on the sitmulation of SRIF release induced by membrane depolarization. No inhibitory effect of the less potent naphthalene sulfonamide agent W5 was observed at 1 .mu.M, although an inhibitory effect was seen at 10 .mu.M. The stimulation of SRIF release induced by A23187 was not inhibited by omission of extracelluar Ca or by verapamil, but was inhibited by EGTA [ethylene glycol bis(aminoethyl ether) N,N,N''N''-tetraacetic acid] and trifluperazine. The role of Ca in membrane depolarization-induced stimulus-secretion coupling of mouse hypothalamic SRIF was demonstrated. Inhibition of the stimulatory response by low concentrations of 3 distinct groups of calmodulin inhibitors, i.e., neuroleptics, naphthalenesulfonamide agents and compound 48/80, suggests a role for calmodulin in this process.This publication has 19 references indexed in Scilit:
- Release of immunoreactive somatostatin from hypothalamic cells in culture: inhibition by gamma-aminobutyric acid.Proceedings of the National Academy of Sciences, 1980
- Acetylcholine Inhibits the Release of Somatostatin from Rat Hypothalamus in Vitro*Endocrinology, 1980
- Neuronal Localization of Ca2+-dependent Protein Phosphorylation in BrainJournal of Neurochemistry, 1980
- CALCIUM-REGULATED MODULATOR PROTEIN INTERACTING AGENTS INHIBIT SMOOTH-MUSCLE CALCIUM-STIMULATED PROTEIN-KINASE AND ATPASE1980
- Stimulation of Ca 2+ -dependent neurotransmitter release and presynaptic nerve terminal protein phosphorylation by calmodulin and a calmodulin-like protein isolated from synaptic vesiclesProceedings of the National Academy of Sciences, 1979
- Potassium stimulated calcium dependent release of immunoreactive somatostatin from incubated rat hypothalamusJournal of Neurochemistry, 1978
- Ca2+-dependent protein phosphorylation system in membranes from various tissues, and its activation by "calcium-dependent regulator".Proceedings of the National Academy of Sciences, 1978
- SOMATOSTATIN IMMUNOREACTIVE PEPTIDES OF HIGHER MOLECULAR WEIGHT IN OVINE HYPOTHALAMIC EXTRACTSJournal of Endocrinology, 1978
- REGIONAL, CELLULAR AND SUBCELLULAR DISTRIBUTION OF CALCIUM‐ACTIVATED CYCLIC NUCLEOTIDE PHOSPHODIESTERASE AND CALCIUM‐DEPENDENT REGULATOR IN PORCINE BRAIN1Journal of Neurochemistry, 1977
- Conversion of big pancreatic somatostatin without peptide bond cleavage into somatostatin tetradecapeptideLife Sciences, 1976